Example: Heart Attack
Search clinical trials for: Methimazole Pill
Total 3 results
-
NCT03447093RecruitingConditions: Microbiota
-
NCT03433352Unknown statusConditions: Microbiota
-
NCT03390582RecruitingConditions: Gut Microbiota
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Show vendors
Medical Conditions
- COVID-19
- ALK-positive NSCLC
- Acute Myeloid Leukemia (AML) in Remission
- Adhesions Pelvic
- Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
- Bone Marrow Disease
- Cervical Spine Degeneration
- Cholesterol, LDL
- Chronic Diabetic Foot Ulcers
- Flap Necrosis
- HPV DNA
- Hemodialysis, Home
- Inflammation Vascular
- Stage IIIB Prostate Cancer AJCC v8
- View Full List
Sponsors and Collaborators
- CHU de Nantes
- Centre International de la Recherche sur le Cancer
- Coretherapix
- European Dairy Association (EDA), Brussels
- Fondo de Investigación Sanitaria (FIS) 2013 Instituto de Salud Carlos III
- Francesco Di Modugno
- Francisco Javier García Borobia
- Healthy Campus Network, University of California, Office of the President
- Marci Lobel-Esrig
- Oogziekenhuis Rotterdam
- Sally Arai
- United Hospital Fund
- Wessex Academic Health Science Network
- View Full List
Drug Interventions
- 5-ASA (5-Aminosalicylate)
- Amphetamine
- BAY2586116
- Dronabinol 5mg Cap
- ES102
- Galiximab in combination with rituximab
- Hydroxocobalamin
- Luspatercept
- MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 6 Weeks
- Pexacerfont
- Prograf (tacrolimus)
- Trastuzumab emtansine (T-DM1)
- Vinorelbine
- View Full List